Revenue: Not disclosed for QQ2 2026 in the provided filing. Top-line visibility remains a material gap for margin and growth analysis.
Gross Profit: $5,536,237; YoY growth 33.29%; QoQ growth 19.45%.
- Interpretation: The magnitude and growth of gross profit suggest improved product mix or favorable unit economics in the quarter, though without a disclosed revenue base, gross margin cannot be computed here. The YoY gain indicates a healthier underlying gross profit contribution relative to the prior year.
EBITDA: $903,071.
- Interpretation: Positive EBITDA supports operating leverage even with limited top-line detail; provides a basis for evaluating ongoing cash-generation potential as SG&A and other costs evolve.
Operating Income: $903,071; YoY growth 741.83%; QoQ growth 119.33%.
- Interpretation: Substantial quarterly expansion in operating profitability—likely driven by cost controls, better product mix, or one-time offsets—improves the company's core profitability trajectory.
Net Income: $704,883; YoY growth 741.94%; QoQ growth 110.86%.
- Interpretation: The company reported a solid net income in QQ2 2026, marking a meaningful uplift versus the prior year and prior quarter, which is favorable for earnings visibility and equity value.
EPS (Basic): $0.10; YoY growth 661.80%; QoQ growth 98.41%.
- Interpretation: The earnings per share expansion aligns with net income improvement and, combined with a relatively small share base, translates into meaningful per-share accretion.
Balance Sheet Highlights:
- Cash and Cash Equivalents: $4,975,968
- Total Current Assets: $12,605,971
- Total Assets: $16,239,654
- Total Current Liabilities: $4,579,472
- Long-Term Debt: $301,012; Short-Term Debt: $206,855; Total Debt: $507,867
- Net Debt: -$4,468,101 (net cash position)
- Total Liabilities: $581,063; Total Stockholders' Equity: $11,079,119
- Current Ratio: ~2.75x; Quick Ratio: ~1.62x
- Leverage (Debt/Equity): ~0.046x
Interpretation: AXIL’s balance sheet displays a strong liquidity profile and a notable net cash position, with low leverage and a healthy current ratio. The substantial net cash position provides capacity to fund marketing, R&D for Reviv3, or strategic initiatives without raising near-term debt. The modest debt burden and solid equity base further support financial resilience in a consumer-packaged goods environment with episodic demand cycles.